Stocks
Aerie Pharmaceuticals (AERI) EBITDA margin US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -941.2% | -238.0% | -141.0% | -4.02% | -1.44% | |||
| Changes by years, y/y, % | +703pp | +97pp | +137pp | -83.8% | |||||
Aerie Pharmaceuticals. EBITDA margin, %
Aerie Pharmaceuticals. EBITDA margin, changes, pp
Aerie Pharmaceuticals (AERI) EBITDA margin US GAAP (quarter values) |
||||||||
| 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | LTM ? | |||
| EBITDA margin, % | ? | -77.3% | 55.2% | -100.4% | -44.2% | -60.2% | -1.44% | |
| Changes by years, y/y, % | +44pp | +157pp | +13pp | +38pp | +17pp | |||
| Changes by quarters, q/q, % | +5pp | +133pp | -156pp | +56pp | -16pp | |||
